GlaxoSmithKline wants to sell more than a third of the space at its R&D campus in Stevenage, UK, to a new bioscience cluster that it says could become one of the largest in Europe.
European and US real estate asset manager and investor, Global Mutual, is delighted to announce that phase 1 of the retrofit ...
CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK manufacturing facility in Stevenage.
Rentschler’s Stevenage cell and gene therapy plant made ... As of June 2023, Rentschler was a tenant alongside GSK, Achilles Therapeutics, and Immunome, amongst others. Rentschler employs ...
GlaxoSmithKline has hired computational drug design specialist Dr Kim Branson to expand its artificial intelligence and machine learning unit. Branson joins the pharma group as senior vice ...
Phase 1 of the retrofit development works of a 90,255 sq ft former GSK laboratory at its 28-acre life science campus, ...